CRISPR Therapeutics AG (CRSP) Selling, General & Administrative (2015 - 2026)
CRISPR Therapeutics AG (CRSP) posted Selling, General & Administrative of $17.55 million for Q2 2026, down 7.2% from $18.92 million a year earlier but up 2.2% from the prior quarter.
Powered by 
Analysis
CRISPR Therapeutics AG (CRSP) Selling, General & Administrative (2015 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at CRISPR Therapeutics AG was $70.07 million, down 5.0% year-over-year; for FY2025, it was $73.54 million, up 0.8% from FY2024.
- Annual Selling, General & Administrative shows a five-year compound annual growth rate of -3.0% (FY2020 to FY2025).
- In prior years, CRISPR Therapeutics AG's Selling, General & Administrative was $72.98 million in FY2024 (-4.2%), $76.16 million in FY2023 (-25.7%), $102.46 million in FY2022 (+2.8%) and $99.69 million in FY2021 (+16.3%).
- Quarterly Selling, General & Administrative has run from a low of $16.48 million in Q4 2023 to a high of $28.02 million in Q1 2022 over five years.
- On a year-over-year basis, Selling, General & Administrative increased in three of the last eight quarters, with an average decline of 1.2%.
- The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q1 2022, with growth of 14.3%; the weakest was Q3 2023, with a decline of 32.3%.
- According to Business Quant data, Selling, General & Administrative for the three prior quarters was $17.18 million (Q1 2026), $18.4 million (Q4 2025) and $16.93 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | CRISPR Therapeutics AG | 5.36 Bn | 5.36 Bn | - | 17.55 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.55 Mn |
| Mar 31, 2026 | 17.18 Mn |
| Dec 31, 2025 | 18.40 Mn |
| Sep 30, 2025 | 16.93 Mn |
| Jun 30, 2025 | 18.92 Mn |
| Mar 31, 2025 | 19.30 Mn |
| Dec 31, 2024 | 18.12 Mn |
| Sep 30, 2024 | 17.42 Mn |
| Jun 30, 2024 | 19.48 Mn |
| Mar 31, 2024 | 17.95 Mn |
| Dec 31, 2023 | 16.48 Mn |
| Sep 30, 2023 | 18.29 Mn |
| Jun 30, 2023 | 19.03 Mn |
| Mar 31, 2023 | 22.36 Mn |
| Dec 31, 2022 | 21.17 Mn |
| Sep 30, 2022 | 27.00 Mn |
| Jun 30, 2022 | 26.27 Mn |
| Mar 31, 2022 | 28.02 Mn |
| Dec 31, 2021 | 23.68 Mn |
| Sep 30, 2021 | 23.71 Mn |
API Access
CRISPR Therapeutics AG Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=CRSP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "CRSP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=CRSP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();